Pharmacogenetics-Based Warfarin Dosing in Patients With Cardiac Valve Replacement: The Effects of CYP2C9 and VKORC1 Gene Polymorphisms.

about

Pharmacogenetics-Based Warfarin Dosing in Patients With Cardiac Valve Replacement: The Effects of CYP2C9 and VKORC1 Gene Polymorphisms.

Item

http://www.wikidata.org/entity/Q47402745

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Pharmacogenetics-Based Warfari ...... and VKORC1 Gene Polymorphisms.

@en

Pharmacogenetics-Based Warfari ...... and VKORC1 Gene Polymorphisms.

@nl

type

Item

label

Pharmacogenetics-Based Warfari ...... and VKORC1 Gene Polymorphisms.

@en

Pharmacogenetics-Based Warfari ...... and VKORC1 Gene Polymorphisms.

@nl

prefLabel

Pharmacogenetics-Based Warfari ...... and VKORC1 Gene Polymorphisms.

@en

Pharmacogenetics-Based Warfari ...... and VKORC1 Gene Polymorphisms.

@nl

P1476

Pharmacogenetics-Based Warfari ...... and VKORC1 Gene Polymorphisms.

@en

P2093

Abbas Afrasiabirad

http://www.w3.org/2001/XMLSchema#string

Ebrahim Sakhinia

http://www.w3.org/2001/XMLSchema#string

Negin Farzamikia

http://www.w3.org/2001/XMLSchema#string

P2860

A simple salting out procedure for extracting DNA from human nucleated cells

A novel functional VKORC1 promoter polymorphism is associated with inter-individual and inter-ethnic differences in warfarin sensitivity.

Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose.

Warfarin pharmacogenetics: CYP2C9 and VKORC1 genotypes predict different sensitivity and resistance frequencies in the Ashkenazi and Sephardi Jewish populations.

Pharmacogenetics of CYP2C9 and interindividual variability in anticoagulant response to warfarin.

Impact of gamma-glutamyl carboxylase gene polymorphisms on warfarin dose requirement: a systematic review and meta-analysis.

Evaluation of genetic factors for warfarin dose prediction

Antithrombotic therapy following bioprosthetic aortic valve replacement.

The largest prospective warfarin-treated cohort supports genetic forecasting

Influence of CYP2C9 and VKORC1 1173C/T genotype on the risk of hemorrhagic complications in African-American and European-American patients on warfarin.

P304

25-34

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/LABMED/LMX072

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-11-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29182754

http://www.w3.org/2001/XMLSchema#string